Literature DB >> 3729345

Pharmacokinetics of cefotaxime, moxalactam, and cefoperazone in the early puerperium.

D Charles, B Larsen.   

Abstract

Twelve parturient women volunteered to receive 1 g of cefotaxime on the second or third day postpartum by intravenous infusion over 3 min. Blood was taken from the antecubital vein of the contralateral arm at 0.25, 0.5, 0.75, 1, 2, 4, and 6 h. The concentration of cefotaxime in serum was assayed by agar diffusion, with Sarcina lutea ATCC 9341 as the indicator strain. The same 12 women received an identical dose of antibiotic 4 months after the first dose, and blood was taken at the same time intervals as in the first study to measure antibiotic levels. An additional 24 women participated in identical studies with either moxalactam or cefoperazone. Cefoperazone afforded the highest concentration in serum of the three drugs, followed by moxalactam. These differences in the concentration in serum were seen both early postpartum and 4 months later. However, the concentration in serum of all three drugs was diminished 2 and 3 days postpartum compared with 4 months postpartum. Most pharmacokinetic parameters were also significantly altered early in the puerperium relative to those obtained 4 months later. The altered pharmacokinetic behavior of antibiotics associated with pregnancy appears to persist into the early puerperium.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3729345      PMCID: PMC284170          DOI: 10.1128/AAC.29.5.873

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Pharmacokinetics of ampicillin during pregnancy.

Authors:  A Philipson
Journal:  J Infect Dis       Date:  1977-09       Impact factor: 5.226

2.  Transfer of cefotaxime in human milk and from mother to foetus.

Authors:  D A Kafetzis; C V Lazarides; C A Siafas; P A Georgakopoulos; C J Papadatos
Journal:  J Antimicrob Chemother       Date:  1980-09       Impact factor: 5.790

3.  Placental transfer of ampicillin.

Authors:  M A MacAulay; M Abou-Sabe; D Charles
Journal:  Am J Obstet Gynecol       Date:  1966-12-01       Impact factor: 8.661

4.  Pharmacokinetics of piperacillin in the postpartum patient.

Authors:  D Charles; B Larsen
Journal:  Gynecol Obstet Invest       Date:  1985       Impact factor: 2.031

5.  Activity of the cefotaxime (HR756) desacetyl metabolite compared with those of cefotaxime and other cephalosporins.

Authors:  R Wise; P J Wills; J M Andrews; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

6.  A study of cefoxitin, moxalactam, and ceftazidime kinetics in pregnancy.

Authors:  H Giamarellou; J Gazis; G Petrikkos; A Antsaklis; D Aravantinos; G K Daikos
Journal:  Am J Obstet Gynecol       Date:  1983-12-15       Impact factor: 8.661

  6 in total
  3 in total

Review 1.  Cefotaxime. An update of its pharmacology and therapeutic use.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

2.  Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development.

Authors:  Sherry Zhao; Mary Gockenbach; Manuela Grimstein; Hari Cheryl Sachs; Mark Mirochnick; Kimberly Struble; Yodit Belew; Jian Wang; Edmund V Capparelli; Brookie M Best; Tamara Johnson; Jeremiah D Momper; Anil R Maharaj
Journal:  Front Pediatr       Date:  2021-10-13       Impact factor: 3.569

Review 3.  Routine antibiotic prophylaxis after normal vaginal birth for reducing maternal infectious morbidity.

Authors:  Mercedes Bonet; Erika Ota; Chioma E Chibueze; Olufemi T Oladapo
Journal:  Cochrane Database Syst Rev       Date:  2017-11-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.